Breast cancer awareness campaigns too often overlook those with metastatic breast cancer. Here's how they can do better

by Rachel Kraus,The ConversationCredit: Unsplash/CC0 Public DomainIs there anyone who isn't aware of breast cancer?Since 1985, cancer-related nonprofits, along with pharmaceutical firms and

Updated on: January 02,2024 8

Breast cancer awareness campaigns too often overlook those with metastatic breast cancer. Here's how they can do better

by Rachel Kraus,The ConversationCredit: Unsplash/CC0 Public DomainIs there anyone who isn't aware of breast cancer?Since 1985, cancer-related nonprofits, along with pharmaceutical firms and

Updated on:January 02,2024 8

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &

Updated on: February 01,2024 12

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &

Updated on:February 01,2024 12

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

Updated on: August 27,2024 0

FDA approves engineered cell therapy for treating rare sarcoma

by Julie Grisham,Memorial Sloan Kettering Cancer CenterCredit: CC0 Public DomainThe U.S. Food and Drug Administration (FDA) hasgranted accelerated approvalfor the immunotherapy afami

Updated on:August 27,2024 0

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on: February 20,2024 11

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on:February 20,2024 11

Experimental blood test improves early detection of pancreatic cancer

byVan Andel Research InstitutePancreatic tissue with the biomarker CA199.STRA in yellow. Credit: Haab Lab, Van Andel InstituteAn experimental blood test detects early-stage pancreatic cancer mor

Updated on: November 11,2024 0

Experimental blood test improves early detection of pancreatic cancer

byVan Andel Research InstitutePancreatic tissue with the biomarker CA199.STRA in yellow. Credit: Haab Lab, Van Andel InstituteAn experimental blood test detects early-stage pancreatic cancer mor

Updated on:November 11,2024 0

New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment

FEBRUARY 2, 2024 Editors' notesby Germans Trias i Pujol Research InstituteCredit: Unsplash/CC0 Public DomainA team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and

Updated on: March 15,2024 8

New therapeutic strategy for metastatic prostate cancer patients resistant to standard treatment

FEBRUARY 2, 2024 Editors' notesby Germans Trias i Pujol Research InstituteCredit: Unsplash/CC0 Public DomainA team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and

Updated on:March 15,2024 8

Activation of a distinct genetic pathway can slow the progress of metastatic breast cancer

by Olivia Newton-John Cancer Research InstituteImmunofluorescent staining reveals activation of the BMP-Smad signaling pathway in metastatic breast cancer cells in response to BMP4 stimulation (left p

Updated on: December 20,2023 15

Activation of a distinct genetic pathway can slow the progress of metastatic breast cancer

by Olivia Newton-John Cancer Research InstituteImmunofluorescent staining reveals activation of the BMP-Smad signaling pathway in metastatic breast cancer cells in response to BMP4 stimulation (left p

Updated on:December 20,2023 15

Incurable but not hopeless: How hope shapes patients' awareness of their advanced cancer prognosis

by Jean Mathews and Michael Brundage,The ConversationCredit: Unsplash/CC0 Public DomainHope is defined as the expectation of achieving a future good. Patients with cancer, whether it is curable

Updated on: March 30,2024 0

Incurable but not hopeless: How hope shapes patients' awareness of their advanced cancer prognosis

by Jean Mathews and Michael Brundage,The ConversationCredit: Unsplash/CC0 Public DomainHope is defined as the expectation of achieving a future good. Patients with cancer, whether it is curable

Updated on:March 30,2024 0

All in the blood: New way to detect drug resistance in ovarian cancer patients

byWalter and Eliza Hall InstituteThe "splicing" mechanism in cancer cells allows them to repair their DNA and avoid the cell death caused by PARP inhibitor therapy, resulting in drug r

Updated on: December 02,2024 0

All in the blood: New way to detect drug resistance in ovarian cancer patients

byWalter and Eliza Hall InstituteThe "splicing" mechanism in cancer cells allows them to repair their DNA and avoid the cell death caused by PARP inhibitor therapy, resulting in drug r

Updated on:December 02,2024 0

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on: January 16,2024 17

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on:January 16,2024 17

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Updated on: January 22,2024 16

Estrogen-negative cancers respond to anti-estrogenic therapies, study shows

byHokkaido UniversityCredit: Nabeel KajiharaAnti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor t

Updated on:January 22,2024 16

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Updated on: January 23,2024 18

Tumor cells' response to chemotherapy is driven by randomness, shows study

byGarvan Institute of Medical ResearchNeuroblastoma cells (cyan) growing as a tumour and the surrounding collagen matrix (magenta). The cells are expressing a biosensor (JNK-KTR) that reads out

Updated on:January 23,2024 18